As federal changes drive up prescription drug costs, new reporting is raising questions about how those policies intersect with the financial interests of Republican U.S. Senate candidate Michael Whatley.
A provision in Trump’s so-called “One Big Beautiful Bill” weakens Medicare’s ability to negotiate lower prices for certain high-cost drugs, delaying or exempting more medications from price controls. That change is expected to increase costs for patients while boosting profits for pharmaceutical companies.
Financial disclosures show that Whatley and his family hold investments valued up to $265,000 in pharmaceutical companies that benefit from those changes. These include major drugmakers whose products are among those affected by delayed price negotiations.
Some of those medications carry steep out-of-pocket costs. A single treatment can cost Medicare patients thousands of dollars, depending on their coverage, adding to the financial strain for seniors and families managing serious illnesses.
The policy changes also come as broader cuts threaten Medicaid coverage that many patients rely on to supplement their care, raising additional concerns about affordability and access.
Whatley played a role in advancing the legislation as a senior Republican Party leader, helping build support for the bill as it moved forward.
The situation underscores a broader concern raised by advocates and voters alike. When policymakers and political leaders hold financial stakes in industries affected by their decisions, it can erode trust and raise questions about whose interests are being served.
“As a cancer survivor on Medicare who relies on my prescription drugs, I can tell you firsthand how important it is that North Carolina seniors are able to afford their prescriptions,” said DonnaMarie Woodson, a North Carolina Medicare Patient, during a NCDP press conference last week. “I can’t stay silent as Michael Whatley profits off of North Carolina seniors who are paying more for life saving medication. We can’t trust Whatley to represent us in the U.S. Senate, because he has shown he will only fight for himself and his bank account, while increasing costs for North Carolina families.”
